| Literature DB >> 19568502 |
Mohammad Tayeb1, Muhammad R Khan, Nazia Riaz.
Abstract
BACKGROUND/AIMS: Although laparoscopic cholecystectomy (LC) has become the procedure of choice for cholelithiasis in the general population, many consider cirrhosis as a relative or absolute contraindication for laparoscopic surgery. The aim of this study was to confirm the safety of LC in cirrhotic patients in our set-up.Entities:
Keywords: Cirrhosis; laparoscopic cholecystectomy; outcome
Year: 2008 PMID: 19568502 PMCID: PMC2702895 DOI: 10.4103/1319-3767.39620
Source DB: PubMed Journal: Saudi J Gastroenterol ISSN: 1319-3767 Impact factor: 2.485
Details of indications, operative procedure, and morbidities related to the procedure
| I. Indications for surgery | |
| Biliary colic | 21 |
| Acute cholecystitis | 06 |
| Gallstone pancreatitis | 03 |
| II. Procedure performed | |
| Laparoscopic cholecystectomy (LC) | 18 |
| Laparoscopic partial cholecystectomy | 04 |
| LC + liver biopsy | 06 |
| LC converted to OC | 02 (6.7%) |
| III. Post-operative morbidities | |
| Total number of patients with complications | 07 (23%) |
| Liver decompensation | 02 |
| Worsening of ascites | 02 |
| Pneumonia + port-site infection | 01 |
| Drop in hemoglobin requiring blood transfusion | 02 |
Comparison of our results with other published reports
| Cucinotta | Poggio | Sleeman | Tayeb | ||
|---|---|---|---|---|---|
| Total number of patients | 22 | 26 | 25 | 30 | |
| Mean age (years) | 58 | 51 | 53 | 42 | |
| Gender | |||||
| Males | 9 | 15 | 8 | 9 | |
| Females | 13 | 11 | 17 | 21 | |
| Etiology of cirrhosis | |||||
| Viral | 18 | 12 | 18 | 24 | |
| Alcohol | 03 | 06 | 04 | 00 | |
| Other | 01 | 08 | 03 | 06 | |
| Diagnosis of cirrhosis | |||||
| Preoperative | 18 | 24 | 19 | 18 | |
| Intraoperative | 04 | 02 | 06 | 12 | |
| Child class | |||||
| A | 12 | 22 | 16 | 24 | |
| B | 10 | 04 | 09 | 06 | |
| C | 00 | 00 | 00 | 00 | |
| Conversion to open | 11% | 12% | 00% | 6.7% | |
| Mean operative time (minutes) | 115 | 114 | - | 81 | |
| Mean hospital stay (days) | 4 | 2.3 | 1.7 | 3 | |
| Complications | 36% | 19% | 32% | 23% | |
| Mortality | 00 | 00 | 00 | 00 |